Expand EVAX Menu
EVAX MENU

EVAX Latest Press Releases

-- August 20, 2026 --

Evaxion announces business update and second quarter 2026 financial results Globe Newswire 7:30 AM

-- August 17, 2026 --

Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program Globe Newswire 8:00 AM

-- August 14, 2026 --

Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026 Globe Newswire 8:00 AM

-- July 17, 2026 --

Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026 Globe Newswire 7:15 AM

-- July 12, 2026 --

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 Globe Newswire 9:30 AM

-- July 1, 2026 --

Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop Globe Newswire 8:00 AM

-- June 12, 2026 --

Evaxion receives Prix Galien UK Award for Best digital health solution Globe Newswire 3:00 AM

-- June 11, 2026 --

Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia Globe Newswire 2:00 AM

-- May 12, 2026 --

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress Globe Newswire 9:30 AM

-- May 7, 2026 --

Evaxion announces business update and first quarter 2026 financial results Globe Newswire 7:30 AM

-- May 4, 2026 --

Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026 Globe Newswire 8:00 AM

-- April 27, 2026 --

Evaxion promotes Birgitte Rn to joint role of Chief Scientific and Chief Operating Officer Globe Newswire 8:00 AM

-- April 17, 2026 --

Evaxion's AI-Immunology platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial Globe Newswire 3:10 PM
New data demonstrates the unique scalability of Evaxion's AI-Immunology platform in glioblastoma Globe Newswire 3:00 PM

-- April 16, 2026 --

Evaxion concludes Annual General Meeting Globe Newswire 11:30 AM

-- April 7, 2026 --

Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01 Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes